English Lixisenatide Cited by user Chris Capoccia on 01 Jul 2019 Lixisenatide (trade name Lyxumia in the Europe and Adlyxin in the U.S. and manufactured by Sanofi) is a once-daily injectable GLP-1 receptor agonist for the treatment of…